MAPK14 and neuroblastoma: Recently, studies performed with the DUSP1/DUSP6 inhibitor BCI showed that p38 activation also upregulates P2X7R levels in neuroblastoma cells, indicating that the DUSP1 phosphatase may negatively modulate P2X7R expression by dampening the p38 pathway [50].